ESC 365 - Panel discussion: the dilemma of stroke versus bleeding in non-valvular atrial fibrillation: are we getting there?

Panel discussion: the dilemma of stroke versus bleeding in non-valvular atrial fibrillation: are we getting there?

Session: Overcoming the dilemma of stroke versus bleeding in non-valvular atrial fibrillation: can we optimise patient care with oral factor Xa inhibition

Topic: Atrial fibrillation (AF)

Speaker: Professor G. Montalescot (Paris, FR) Professor A. Goette (Paderborn, DE) Professor J. Alexander (Durham, US) Professor P. Kirchhof (Hamburg, DE) Professor S. Connolly (Hamilton, CA)

Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Event: ESC CONGRESS 2014

About the speakers

Professor Gilles Montalescot

Pitie Salpetriere APHP University Hospital, Paris (France)

32 presentations

1 follower

Professor Andreas Goette

Saint Vincenz Hospital Paderborn, Paderborn (Germany)

40 presentations

0 follower

Professor John Alexander

Duke University Medical Center, Durham (United States of America)

3 presentations

0 follower

Professor Paulus Kirchhof

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

60 presentations

5 followers

Professor Stuart Connolly

Hamilton (Canada)

0 follower

5 more presentations in this session

Chairs' introduction: improving patient care, a joint commitment.

Speaker: Professor G. Montalescot (Paris, FR) Professor H. Bueno (Madrid, ES)

Access

Slides

Stroke prevention in atrial fibrillation with oral factor Xa inhibitors: learnings from patient profiles.

Speaker: Professor A. Goette (Paderborn, DE)

Access

Slides

Refining treatment in atrial fibrillation: the coronary artery disease patient.

Speaker: Professor J. Alexander (Durham, US)

Access

Slides

Apixaban and interventional procedures in atrial fibrillation: what have we learnt and what will we learn?

Speaker: Professor P. Kirchhof (Hamburg, DE)

Access

Slides

Under the tip of the atrial fibrillation iceberg: improving the care of undertreated patients.

Speaker: Professor S. Connolly (Hamilton, CA)

Access

Slides

Access the full session

Overcoming the dilemma of stroke versus bleeding in non-valvular atrial fibrillation: can we optimise patient care with oral factor Xa inhibition

Speakers: Professor G. Montalescot, Professor A. Goette, Professor J. Alexander, Professor P. Kirchhof, Professor S. Connolly...

Access

About the event

ESC CONGRESS 2014

30 August - 3 September 2014

Sessions Presentations

Panel discussion: the dilemma of stroke versus bleeding in non-valvular atrial fibrillation: are we getting there?

About the speakers

Professor Gilles Montalescot

Professor Andreas Goette

Professor John Alexander

Professor Paulus Kirchhof

Professor Stuart Connolly

5 more presentations in this session

Chairs' introduction: improving patient care, a joint commitment.

Stroke prevention in atrial fibrillation with oral factor Xa inhibitors: learnings from patient profiles.

Refining treatment in atrial fibrillation: the coronary artery disease patient.

Apixaban and interventional procedures in atrial fibrillation: what have we learnt and what will we learn?

Under the tip of the atrial fibrillation iceberg: improving the care of undertreated patients.

Access the full session

Overcoming the dilemma of stroke versus bleeding in non-valvular atrial fibrillation: can we optimise patient care with oral factor Xa inhibition

About the event

ESC CONGRESS 2014

ESC 365 is supported by